MOEX: PRMD - ПРОМОМЕД ДМ

Yield per half year: +6.26%
Dividend yield: 0.00%
Sector: Фармацевтика

Current price
433
Average price
580.78+34.13%

Average analyst price
531.67+22.79%
Price based on EPS
315.45-27.15%
6.67/10

Average analyst price

Fair price = 531.67
Current price = 433 ₽ (difference = +22.79%)

Idea Price forecast Changes Expiration date Analyst
Промомед: не забудь про таблетки 670 ₽ +237 ₽ (54.73%) 14.01.2026 БКС
Промомед: препараты для роста 435 ₽ +2 ₽ (0.4619%) 17.10.2025 Финам
Промомед: выпускается без рецепта 490 ₽ +57 ₽ (13.16%) 09.07.2025 КИТ Финанс

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 315.45
Current price = 433 ₽ (difference = -27.15%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 895.21
Current price = 433 ₽ (difference = +106.75%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -851.38
Current price = 433 ₽ (difference = -296.62%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription